III.C.27.   Dose to the patient.

___  ___   ___   ___   ___

    A.   Radionuclide
    B.   Administered activity
    C.   Half life
    D.   Imaging time
    E.   Type of collimator
    F.   Patient-collimator distance
    G.   PHA window level
    H.   PHA window width